Found 20 matching trials
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone PHASE4 The main objective of this study is to evaluate the efficacy of SZC as comp...
Show More Learn More & Join Trial
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients PHASE3 Heart failure (HF) and Chronic Kidney Disease (CKD) patients are frequently...
Show More Location
Hospital Universitario Fundación Alcorcón
Learn More & Join Trial
Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia PHASE4 Prescribing Sodium zirconium cyclosilicate (SZC) with enhanced nutritional ...
Show More Learn More & Join Trial
Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study PHASE4 This is an open-label, randomised study in participants with chronic kidney...
Show More Learn More & Join Trial
Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects PHASE1 This study will be an open-label, randomised sequence, 2-period, 2-cohort, ...
Show More Learn More & Join Trial
Swedish Cardiac And Renal Failure Study-1 PHASE2 Previous studies have shown that patients with heart failure with reduced p...
Show More Location
Department of Cardiology, Danderyd Hospital, Karolinska Institutet
Learn More & Join Trial
Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes) PHASE3 The purpose of this study is to evaluate the effect of Sodium Zirconium Cyc...
Show More Learn More & Join Trial
Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial) PHASE1 This study hypothesizes that the administration of Sodium zirconium cyclosi...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients PHASE4 The management of serum potassium in maintenance hemodialysis(MHD )patients...
Show More Location
Multiple Locations
Learn More & Join Trial
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure PHASE2 Mineralocorticoid receptor antagonists (MRA) is one of cornerstones in the ...
Show More Status
Active Not Recruiting
Location
Section of Cardiology, Sahlgrenska University Hospital-Östra Hospital
Learn More & Join Trial